Syrian President Bashar al-Assad’s family members and associates rely on the illicit drug trade to fund his regime’s violent oppression and abuse of the Syrian people.  Today, the United States is taking action, in coordination with the United Kingdom, by designating six of these individuals, and two entities owned by one of those individuals, for facilitating the production and export of the amphetamine-type stimulant known as Captagon in Syria and Lebanon.

The individuals and entities being designated today have enabled the Syrian regime to continue carrying out abuses against the Syrian people by providing funds to the regime derived from trade in illicit drugs.

The United States will continue to coordinate with our allies and partners to target traffickers of illicit drugs and those who provide support to the Syrian regime’s vicious war.

For more information about these designations, please see the Department of the Treasury’s press release.